StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
499
This month
6
This year
34
Publishing Date
2024 - 03 - 28
3
2023 - 07 - 24
4
2023 - 05 - 15
3
2022 - 12 - 09
4
2022 - 09 - 13
3
2022 - 08 - 15
3
2022 - 07 - 04
2
2022 - 06 - 03
3
2022 - 05 - 24
2
2022 - 04 - 20
2
2022 - 04 - 19
2
2022 - 04 - 13
2
2022 - 03 - 28
2
2022 - 02 - 28
2
2022 - 02 - 24
2
2022 - 02 - 10
2
2022 - 02 - 01
2
2022 - 01 - 18
2
2022 - 01 - 14
2
2022 - 01 - 10
3
2021 - 12 - 21
2
2021 - 11 - 29
4
2021 - 11 - 19
2
2021 - 11 - 15
2
2021 - 11 - 11
2
2021 - 10 - 28
2
2021 - 10 - 21
2
2021 - 10 - 14
2
2021 - 10 - 07
2
2021 - 09 - 20
3
2021 - 09 - 16
3
2021 - 08 - 19
2
2021 - 08 - 12
3
2021 - 08 - 10
2
2021 - 08 - 05
3
2021 - 08 - 04
2
2021 - 07 - 29
2
2021 - 07 - 12
2
2021 - 06 - 25
2
2021 - 06 - 24
4
2021 - 06 - 23
2
2021 - 06 - 22
2
2021 - 06 - 21
3
2021 - 06 - 17
2
2021 - 06 - 10
2
2021 - 06 - 09
2
2021 - 06 - 04
5
2021 - 05 - 20
3
2021 - 05 - 06
2
2021 - 04 - 15
2
2021 - 04 - 14
2
2021 - 04 - 13
2
2021 - 03 - 22
2
2021 - 03 - 19
2
2021 - 03 - 18
2
2021 - 03 - 15
2
2021 - 03 - 11
3
2021 - 03 - 09
2
2021 - 03 - 04
2
2021 - 01 - 11
2
Sector
Communications
8
Distribution services
1
Electronic technology
3
Finance
7
Health services
3
Health technology
499
Manufacturing
15
N/a
4
Process industries
5
Professional, scientific, and technical services
8
Retail trade
1
Technology services
4
Tags
Agreement
12
Alliances
22
Antiviral
12
Application
9
Approval
16
Bioscience
10
Biotech
9
Biotech-bay
48
Biotech-beach
11
Breast cancer
22
Cancer
59
Chmp
11
Clinical-trials-phase-iii
14
Collaboration
23
Conference
14
Covid
14
Covid-19
16
Disease
20
Drug
25
Earnings
17
Events
20
Fda
21
Fda-approvals
10
Financial
23
Financial results
20
Genetown
11
Global
35
Growth
10
Health
13
Hepatitis
19
Hiv
41
Leukemia
10
License
13
Liver
11
Market
48
Money
9
N/a
225
People
19
Pharma
12
Pharmaceutical
10
Phase 2
9
Phase 3
9
Positive
13
Potential
10
Pre-clinical
9
Preclinical
10
Report
19
Research
54
Results
51
Sciences
29
Study
11
T-cell
32
Technology
9
Therapeutics
42
Therapy
52
Treatment
50
Trial
23
Trodelvy
15
Year
9
Yescarta
14
Entities
Aadi biosciences inc
3
Abbott laboratories
12
Abbvie inc.
41
Adaptimmune therapeutics plc
3
Allovir, inc.
3
Alnylam pharmaceuticals, inc.
6
Amgen inc.
35
Arcellx, inc.
7
Arcus biosciences, inc.
3
Assembly biosciences, inc.
6
Astellas pharma inc
3
Astrazeneca plc
10
Baxter international inc.
3
Biocryst pharmaceuticals, inc.
13
Biogen inc.
6
Biomarin pharmaceutical inc.
4
Biontech se
3
Bluebird bio, inc.
4
Bristol-myers squibb company
45
Calliditas therapeutics ab
3
Crispr therapeutics ag
3
Cymabay therapeutics inc.
3
Editas medicine, inc.
3
Eli lilly and company
35
Exelixis, inc.
3
Galapagos nv
20
Genmab a/s
4
Gilead sciences, inc.
499
Glaxosmithkline plc
24
Hookipa pharma inc.
16
Humanigen, inc.
3
Immunogen, inc.
4
Intellia therapeutics, inc.
3
Johnson & johnson
43
Jounce therapeutics, inc.
25
Macrogenics, inc.
5
Merck & company, inc.
5
Morphosys ag
4
Novartis ag
28
Novo nordisk a/s
10
Nrx pharmaceuticals inc
3
Nurix therapeutics, inc.
4
Omeros corporation
14
Orange
8
Otonomy, inc.
13
Pfizer, inc.
27
Regeneron pharmaceuticals, inc.
11
Sangamo therapeutics, inc.
4
Sanofi
64
Sarepta therapeutics, inc.
4
Sorrento therapeutics, inc.
4
Takeda pharmaceutical company limited
15
Teva pharmaceutical industries ltd
10
Thermo fisher scientific inc
4
Vertex pharmaceuticals incorporated
6
Veru inc.
4
Viatris inc.
5
Vir biotechnology, inc.
6
Xeris pharmaceuticals, inc.
11
Xilio therapeutics inc
4
Symbols
AADI
3
ABBV
41
ABT
12
ACLX
7
ADAP
3
ALNY
6
ALPMF
3
ALPMY
3
ALVR
3
AMGN
35
ASMB
6
AZN
10
AZNCF
8
BAX
3
BCRX
13
BIIB
6
BLUE
4
BMRN
4
BMY
45
BNTX
3
CALT
3
CBAY
3
CRSP
3
FNCTF
8
GILD
499
GLAXF
19
GLPG
20
GLPGF
16
GMAB
4
GSK
24
HOOK
16
IMGN
4
JNCE
25
JNJ
43
LLY
35
MGNX
5
MOR
4
MRK
5
NRIX
4
NVO
10
NVS
28
NVSEF
25
OMER
14
OTIC
13
PFE
27
REGN
11
SGMO
4
SNY
64
SNYNF
35
SRNE
4
SRPT
4
TAK
15
TEVJF
10
TMO
4
VERU
4
VIR
6
VRTX
6
VTRS
5
XERS
11
XLO
4
Exchanges
Amex
2
Nasdaq
499
Nyse
116
Crawled Date
2024 - 03 - 28
3
2023 - 12 - 12
3
2023 - 07 - 24
3
2023 - 06 - 01
3
2023 - 05 - 15
3
2022 - 12 - 09
4
2022 - 09 - 13
3
2022 - 06 - 03
3
2022 - 04 - 20
2
2022 - 04 - 19
2
2022 - 04 - 13
2
2022 - 03 - 31
2
2022 - 03 - 28
2
2022 - 02 - 28
2
2022 - 02 - 10
2
2022 - 02 - 01
2
2022 - 01 - 19
2
2022 - 01 - 14
2
2022 - 01 - 10
3
2021 - 12 - 21
2
2021 - 12 - 15
2
2021 - 11 - 29
4
2021 - 11 - 19
2
2021 - 11 - 15
2
2021 - 11 - 11
2
2021 - 10 - 28
2
2021 - 10 - 21
2
2021 - 10 - 14
2
2021 - 10 - 07
2
2021 - 09 - 20
3
2021 - 09 - 16
3
2021 - 08 - 19
2
2021 - 08 - 12
3
2021 - 08 - 10
2
2021 - 08 - 05
3
2021 - 08 - 04
2
2021 - 07 - 29
2
2021 - 07 - 12
2
2021 - 06 - 25
2
2021 - 06 - 24
4
2021 - 06 - 23
2
2021 - 06 - 22
3
2021 - 06 - 21
2
2021 - 06 - 17
2
2021 - 06 - 10
2
2021 - 06 - 09
2
2021 - 06 - 04
5
2021 - 05 - 20
3
2021 - 05 - 06
2
2021 - 04 - 15
2
2021 - 04 - 14
2
2021 - 04 - 13
3
2021 - 03 - 22
2
2021 - 03 - 19
2
2021 - 03 - 18
2
2021 - 03 - 15
2
2021 - 03 - 11
4
2021 - 03 - 09
2
2021 - 03 - 04
2
2021 - 01 - 11
2
Crawled Time
00:00
19
00:20
2
01:00
17
02:00
2
03:00
3
04:00
3
04:20
1
06:00
5
07:00
7
08:00
6
09:00
7
09:52
1
10:00
7
10:51
1
11:00
33
11:33
3
12:00
41
12:03
1
12:06
1
12:15
12
12:20
6
12:30
1
12:34
1
13:00
44
13:01
1
13:07
1
13:15
5
13:17
1
13:20
19
13:27
1
13:30
3
13:52
1
14:00
39
14:01
1
14:03
2
14:15
3
14:20
6
14:30
10
15:00
22
15:15
2
15:17
1
15:20
3
15:30
4
15:49
1
15:56
1
15:59
1
16:00
14
16:20
2
17:00
17
17:43
1
18:00
12
18:11
1
18:32
1
19:00
10
19:47
1
20:00
24
21:00
17
21:03
1
22:00
27
23:00
19
Source
galmedpharma.com
1
investor.assemblybio.com
1
ir.voyagertherapeutics.com
1
www.biospace.com
273
www.fda.gov
19
www.globenewswire.com
80
www.igmbio.com
1
www.nurixtx.com
1
www.prnewswire.com
122
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
entities :
Gilead sciences, inc.
symbols :
Gild
save search
Citius Pharmaceuticals Announces Addition of City of Hope to UMN's Phase 1 Trial of LYMPHIR in Combination with CAR-T for the Treatment of B-Cell Lymphoma
Published:
2024-04-11
(Crawled : 20:00)
- biospace.com/
FNCTF
|
$11.0354
-20.84%
320
|
Communications
|
-1.12%
|
O:
-0.29%
H:
0.0%
C:
0.0%
GILD
|
$66.94
-0.55%
-0.55%
5.3M
|
Health Technology
|
-1.19%
|
O:
0.5%
H:
0.83%
C:
0.28%
CTXR
|
$0.827
10.3%
9.33%
680K
|
Health Technology
|
-11.81%
|
O:
2.33%
H:
2.28%
C:
-4.23%
hope
treatment
pharmaceuticals
city
for
car-t
trial
Leap Therapeutics Announces $40 Million Private Placement
Published:
2024-04-11
(Crawled : 20:00)
- biospace.com/
LPTX
|
$2.96
-0.67%
-0.68%
150K
|
Health Technology
|
-1.97%
|
O:
15.13%
H:
25.43%
C:
-11.0%
GILD
|
$66.94
-0.55%
-0.55%
5.3M
|
Health Technology
|
-1.19%
|
O:
0.5%
H:
0.83%
C:
0.28%
million
leap
therapeutics
Gilead Sciences to Release First Quarter 2024 Financial Results on Thursday, April 25, 2024
Published:
2024-04-08
(Crawled : 23:00)
- biospace.com/
GILD
|
$66.94
-0.55%
-0.55%
5.3M
|
Health Technology
|
-3.26%
|
O:
-0.76%
H:
0.72%
C:
0.54%
gilead
first
sciences
financial
results
RedHill Biopharma Announces Full-Year 2023 Results and Operational Highlights
Published:
2024-04-08
(Crawled : 13:30)
- prnewswire.com
RDHL
|
$0.3935
2.21%
2.16%
240K
|
Health Technology
|
-27.22%
|
O:
0.57%
H:
0.0%
C:
-1.5%
GILD
|
$66.94
-0.55%
-0.55%
5.3M
|
Health Technology
|
-3.26%
|
O:
-0.76%
H:
0.72%
C:
0.54%
biopharma
results
Pulmonx Announces Appointment of Mehul Joshi as Chief Financial Officer
Published:
2024-04-02
(Crawled : 20:00)
- globenewswire.com
RMD
|
$173.83
-5.97%
0.09%
3M
|
Health Technology
|
0.27%
|
O:
0.88%
H:
1.64%
C:
0.03%
LUNG
|
$7.44
0.27%
0.27%
360K
|
Health Technology
|
-12.81%
|
O:
0.59%
H:
1.64%
C:
-7.13%
GILD
|
$66.94
-0.55%
-0.55%
5.3M
|
Health Technology
|
-6.63%
|
O:
-0.12%
H:
0.24%
C:
-1.54%
financial
Xilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2023 Financial Results
Published:
2024-04-01
(Crawled : 20:00)
- globenewswire.com
GILD
|
$66.94
-0.55%
-0.55%
5.3M
|
Health Technology
|
-7.64%
|
O:
-0.08%
H:
0.04%
C:
-1.0%
business
year
pipeline
therapeutics
financial
results
Global Acute Lymphoblastic Leukemia Therapeutics Market Research 2024-2033: Developments Review, Regulatory Landscape, Competitive Benchmarking, Dynamic Landscape
Published:
2024-03-29
(Crawled : 18:00)
- prnewswire.com
BMY
|
$47.84
-0.87%
-0.02%
12M
|
Health Technology
|
Email alert
Add to watchlist
GILD
|
$66.94
-0.55%
-0.55%
5.3M
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
$92.116
-2.18%
2.3K
|
Health Technology
|
Email alert
Add to watchlist
AMGN
|
$264.07
-0.59%
-0.59%
2.2M
|
Health Technology
|
Email alert
Add to watchlist
GMAB
|
$28.51
-3.13%
-3.23%
360K
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
$93.08
-0.13%
0.86%
1.2M
|
Health Technology
|
Email alert
Add to watchlist
GNMSF
|
$285.11
3.83%
420
|
Health Technology
|
Email alert
Add to watchlist
ABBV
|
$164.25
1.05%
-0.76%
4M
|
Health Technology
|
Email alert
Add to watchlist
research
global
leukemia
therapeutics
market
Assembly Biosciences Reports Fourth Quarter and Year End 2023 Financial Results and Recent Highlights
Published:
2024-03-28
(Crawled : 20:00)
- globenewswire.com
ASMB
|
$12.92
-11.02%
-12.38%
26K
|
Health Technology
|
Email alert
Add to watchlist
GILD
|
$66.94
-0.55%
-0.55%
5.3M
|
Health Technology
|
Email alert
Add to watchlist
year
financial
results
Xilio Therapeutics Announces $11.3 Million Private Placement Equity Financing
Published:
2024-03-28
(Crawled : 11:00)
- globenewswire.com
XLO
|
$1.235
-5.0%
-5.26%
440K
|
Professional, Scientific, and T...
|
103.44%
|
O:
200.47%
H:
0.52%
C:
-43.75%
GILD
|
$66.94
-0.55%
-0.55%
5.3M
|
Health Technology
|
-7.81%
|
O:
0.33%
H:
0.85%
C:
0.0%
million
therapeutics
Gilead and Xilio Announce Exclusive License Agreement for Tumor-Activated IL-12 Program
Published:
2024-03-28
(Crawled : 11:00)
- globenewswire.com
XLO
|
$1.235
-5.0%
-5.26%
440K
|
Professional, Scientific, and T...
|
103.44%
|
O:
200.47%
H:
0.52%
C:
-43.75%
GILD
|
$66.94
-0.55%
-0.55%
5.3M
|
Health Technology
|
-7.81%
|
O:
0.33%
H:
0.85%
C:
0.0%
il-12
license
program
agreement
Everest Medicines Announces Financial Results for Full Year Ended December 31, 2023
Published:
2024-03-27
(Crawled : 23:00)
- prnewswire.com
GILD
|
$66.94
-0.55%
-0.55%
5.3M
|
Health Technology
|
-7.81%
|
O:
0.33%
H:
0.85%
C:
0.0%
year
financial
results
Hepatitis B and C diagnostics market size to increase by USD 2.05 billion, Technavio
Published:
2024-03-27
(Crawled : 14:30)
- prnewswire.com
DHR
|
$239.39
-0.4%
0.03%
2.9M
|
Health Technology
|
-3.27%
|
O:
0.56%
H:
0.16%
C:
-0.43%
ABT
|
$105.9
-3.03%
0.07%
12M
|
Health Technology
|
-1.11%
|
O:
1.48%
H:
0.0%
C:
0.0%
VIR
|
$8.255
-1.26%
-1.27%
760K
|
Health Technology
|
-16.15%
|
O:
0.4%
H:
2.3%
C:
0.9%
GILD
|
$66.94
-0.55%
-0.55%
5.3M
|
Health Technology
|
-7.04%
|
O:
0.7%
H:
0.19%
C:
0.12%
hepatitis
diagnostics
market
Gilead Sciences Announces Completion of Acquisition of CymaBay
Published:
2024-03-22
(Crawled : 22:00)
- biospace.com/
GILD
|
$66.94
-0.55%
-0.55%
5.3M
|
Health Technology
|
-7.91%
|
O:
0.03%
H:
0.16%
C:
-0.68%
acquisition
sciences
HOOKIPA Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
Published:
2024-03-22
(Crawled : 11:00)
- globenewswire.com
HOOK
|
$0.7633
-5.75%
-6.11%
490K
|
Health Technology
|
11.85%
|
O:
3.58%
H:
0.0%
C:
-5.19%
GILD
|
$66.94
-0.55%
-0.55%
5.3M
|
Health Technology
|
-7.91%
|
O:
0.03%
H:
0.16%
C:
-0.68%
pharma
business
year
financial
results
Global Neutropenia Market Poised to Reach USD 5.86 Billion by 2028, Amid Rising Cancer Incidence and Advancements in Treatment Options
Published:
2024-03-18
(Crawled : 00:00)
- prnewswire.com
SNYNF
|
$92.116
-2.18%
2.3K
|
Health Technology
|
-2.92%
|
O:
-0.02%
H:
0.0%
C:
0.0%
BAX
|
$39.52
-0.13%
0.0%
2.8M
|
Health Technology
|
-4.74%
|
O:
0.02%
H:
1.03%
C:
0.96%
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-4.5%
|
O:
-1.51%
H:
0.0%
C:
0.0%
GILD
|
$66.94
-0.55%
-0.55%
5.3M
|
Health Technology
|
-8.12%
|
O:
0.11%
H:
0.59%
C:
0.1%
BIIB
|
$192.13
-1.55%
-1.57%
1.3M
|
Health Technology
|
-11.05%
|
O:
-0.48%
H:
0.31%
C:
0.13%
reach
cancer
treatment
global
market
Gilead and Merus Announce Collaboration to Discover Novel Antibody-Based Trispecific T-Cell Engagers
Published:
2024-03-06
(Crawled : 15:30)
- biospace.com/
MRUS
|
$41.01
1.74%
1.71%
410K
|
Health Technology
|
-19.33%
|
O:
0.06%
H:
1.66%
C:
-2.56%
GILD
|
$66.94
-0.55%
-0.55%
5.3M
|
Health Technology
|
-7.78%
|
O:
-0.15%
H:
0.6%
C:
-0.34%
t-cell
collaboration
Gilead Sciences CEO on Company's Evolution and Commitment to the Bay Area
Published:
2024-03-05
(Crawled : 14:30)
- biospace.com/
GILD
|
$66.94
-0.55%
-0.55%
5.3M
|
Health Technology
|
-6.84%
|
O:
0.21%
H:
0.84%
C:
0.81%
ceo
bay
sciences
CymaBay Reports Fourth Quarter and Year Ended December 31, 2023 Financial Results and Provides Corporate Update
Published:
2024-02-28
(Crawled : 22:00)
- globenewswire.com
GILD
|
$66.94
-0.55%
-0.55%
5.3M
|
Health Technology
|
-7.41%
|
O:
0.03%
H:
0.26%
C:
-0.85%
CBAY
|
$32.48
0.03%
8.4M
|
Health Technology
|
0.62%
|
O:
0.02%
H:
0.0%
C:
0.0%
year
update
financial
results
Arcellx Provides Fourth Quarter and Year-End 2023 Financial Results and Business Highlights
Published:
2024-02-28
(Crawled : 21:00)
- prnewswire.com
ACLX
|
$53.52
-3.08%
-3.18%
440K
|
|
-17.97%
|
O:
3.09%
H:
0.94%
C:
-5.16%
GILD
|
$66.94
-0.55%
-0.55%
5.3M
|
Health Technology
|
-7.41%
|
O:
0.03%
H:
0.26%
C:
-0.85%
business
financial
results
Gilead to Present Late-Breaking Data and Real-World Evidence Highlighting Innovative Antiviral Portfolio and Research Pipeline at CROI 2024
Published:
2024-02-26
(Crawled : 14:30)
- biospace.com/
GILD
|
$66.94
-0.55%
-0.55%
5.3M
|
Health Technology
|
-8.48%
|
O:
-0.07%
H:
0.53%
C:
-0.75%
antiviral
pipeline
research
← Previous
1
2
3
4
5
6
7
8
9
…
24
25
Next →
Gainers vs Losers
57%
43%
Top 10 Gainers
INVO
|
$1.76
131.58%
56.82%
230M
|
Health Technology
SINT
|
$0.0365
59.39%
37.26%
470M
|
Health Technology
WISA
4
|
$9.19
50.66%
33.7%
65M
|
Electronic Technology
EDBL
|
$6.73
47.91%
32.39%
13M
|
GCTK
|
$0.715
36.27%
26.62%
640K
|
Manufacturing
TCON
|
$2.33
36.26%
26.61%
1.9M
|
Health Technology
TIRX
|
$0.48
6.43%
24.58%
800K
|
KZIA
|
$0.38
30.58%
23.42%
300K
|
Health Technology
VNDA
|
$5.23
29.14%
22.56%
24M
|
Health Technology
ATNF
|
$1.91
29.05%
22.51%
310K
|
Your saved searches
Save your searches and get alerts when important news are released.